Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Likes Consumer Business Fit As Segment Grows 8%

This article was originally published in The Tan Sheet

Executive Summary

Increased sales of core brands including Advil, Caltrate and Robitussin drove up consumer sales 8% to $817 million for Pfizer’s fourth quarter. CEO Ian Read sees the segment “fitting nicely” in Pfizer following its animal health and nutrition business divestments.

Advertisement

Related Content

J&J Bit Off More Than McNeil Could Chew In 2006 Pfizer OTC Acquisition
J&J Bit Off More Than McNeil Could Chew In 2006 Pfizer OTC Acquisition
J&J Bit Off More Than McNeil Could Chew In 2006 Pfizer OTC Acquisition
J&J Bit Off More Than McNeil Could Chew In 2006 Pfizer OTC Acquisition
J&J Bit Off More Than McNeil Could Chew In 2006 Pfizer OTC Acquisition
Pfizer Reorganizes Internally, Closer To Decision On Splitting Business
Pfizer Reorganizes Internally, Closer To Decision On Splitting Business
Pfizer Will Unload Nutrition Division, Keep Consumer Product Unit
Freed From Pfizer, Capsugel May Find More Market Opportunities
Pfizer Plans To Give Diversified Businesses Time To Grow

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel